A Phase II Study of 2 Doses of ZD6474 (Vandetanib) in Combination With FOLFOX vs FOLFOX Alone for the Treatment of Colorectal Cancer

NCT00500292 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

109

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal
Cancer

Interventions

DRUG: Vandetanib
DRUG: FOLFOX regimen=oxaliplatin, fluorouracil, & folinic acid

Sponsor

Genzyme, a Sanofi Company